CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...